Skip to content

Glioma and Pregnancy

Glioma and Pregnancy - GAP

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034035
Enrollment
300
Registered
2024-07-01
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71

Interventions

Group 1: Female patients suffering from glioma and wishing to become pregnant before, during or after glioma therapy - Analysis of progression-free and overall survival - Analysis of Quality of life,

Sponsors

Universitätsklinikum Frankfurt
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Glioma diagnosis Wish to become pregnant or pregnancy at glioma diagnosis

Exclusion criteria

Exclusion criteria: Patients´ unability to participate in the study No consent to study participation

Design outcomes

Primary

MeasureTime frame
Progression-free and overall survival Quantification or residual tumor growth (or tumor recurrence) during pregnancy

Secondary

MeasureTime frame
Data of female patients´ cycle and ovarian reserve before/ during/ after adjuvant treatment and 1 year after surgery Data on children's birth Data on quality of life Data on fertility protection Identification of hormone receptors, altered signal transduction or genetic alterations in tumor cells after pregnancy in case of tumor re-resection

Countries

Germany

Contacts

Public ContactMarie-Therese Forster

Universitätsklinikum Frankfurt

Marie-Therese.Forster@med.uni-frankfurt.de+496963015295

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026